Dennie Meijer

14PUBLICATIONS
22CO-AUTHORS
Radiation therapyPredictive and prognostic markersCancer diagnosisAdolescent healthPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 10, 2026
Observational Management for Patients with Biochemical Recurrence Following Radical Prostatectomy, in the Absence of Detectable Disease on Restaging PSMA PET/CT Imaging.

Katelijne C C de Bie, Jan-Jaap J Mellema, Dennie Meijer

|Oct 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Bart Geboers, Dennie Meijer, William Counter

|Aug 24, 2023
Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.

Yves J L Bodar, Liselotte M S Boevé, Pim J van Leeuwen

|Jul 29, 2023
Higher Preoperative Maximum Standardised Uptake Values (SUVmax) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [68Ga]Ga-PSMA-11 and [18F]DCFPyL Positron Emission Tomography/Computed Tomography.

Katelijne C C de Bie, Hans Veerman, Yves J L Bodar

|Mar 29, 2023
Identifying Patients in Whom the Follow-Up Scheme after Robot-Assisted Radical Prostatectomy Could Be Optimized in the First Year after Surgery: Reducing Healthcare Burden.

Hans Veerman, Sophia H van der Graaf, Dennie Meijer

|Sep 19, 2022
The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography.

Hans Veerman, Maarten Donswijk, Elise Bekers

Pageof 3

Frequent Collaborators

3 joint publications

Henk G van der Poel

3 joint publications

Yves J L Bodar

3 joint publications

Hans Veerman

3 joint publications

Maarten L Donswijk